Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer

Title
Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 17, Issue 11, Pages 3716-3726
Publisher
American Association for Cancer Research (AACR)
Online
2011-04-22
DOI
10.1158/1078-0432.ccr-11-0233

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now